https://www.marketscreener.com/quote/stock/ATHENEXPAR-35806862/news/Athenex-Presents-Data-from-Oral-Paclitaxel-Pembrolizumab-Phase-1-Study-at-ESMO-2021-36439022/?utm_source=telegram&utm_medium=social&utm_campaign=share